This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
Virtual screening approaches are becoming a more essential tool for finding leads. VS is a computational technique that searches virtual fragment libraries for probable hits using computer algorithms. VS is a computational technique that uses a large and diverse library of chemical compounds to discover lead molecules. In comparison to an experimental strategy such as high-throughput screening, VS is a crucial technique for creating lead compounds since it is faster, more cost-effective, and less resource-intensive. Virtual screening has grown in popularity as a technique for developing alternative ways for choosing an appropriate selection of compounds, minimizing excessive resource expenses, and preventing the generation of unwanted compounds. Virtual screening has the potential to play a unique role in studying the interactions of all existing natural compounds with all potential targets. Virtual screening, which uses either structure-based approaches (protein structure or homology model with known/identified binding site) or ligand-based approaches to find novel hits, is a strong way to find new hits (chemical structures of known modulators of the target).
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt